Valeant Pharmaceuticals International Financial Analyst Salaries in Boulder
The average Valeant Pharmaceuticals International Financial Analyst in Boulder earns an estimated $78,095 annually, which includes an estimated base salary of $71,762 with a $6,333 bonus. Valeant Pharmaceuticals International's Financial Analyst compensation is $9,304 less than the US average for a Financial Analyst. Financial Analyst salaries at Valeant Pharmaceuticals International in Boulder can range from $57,500 - $86,000.
In Boulder, The Finance Department at Valeant Pharmaceuticals International earns $5,365 more on average than the Operations Department.
Last updated 2 years ago.
- $71,762
- avg. base
- $6,333
- avg. bonus
Financial Analyst Salaries at Valeant Pharmaceuticals International
In Boulder, Financial Analysts earn $3,244 more than Financial Analysts, and $2,685 less than Business Analysts.
Compensation at Valeant Pharmaceuticals International by Department
In Boulder, The Finance Department averages $5,365 more than the Operations Department, and $15,524 less than the Sales Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Financial Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Financial Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
